C. Burri

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
C Burri, C. Burri, Christian Burri
Publication record
99 papers · 4,828 citations · H-index 31

PAPERS

Correction: Health worker compliance with severe malaria treatment guidelines in the context of implementing pre-referral rectal artesunate in the Democratic Republic of the Congo, Nigeria, and Uganda: An operational study
20230 citationsauthor #26
Pre-referral rectal artesunate is no “magic bullet” in weak health systems
20232 citationsauthor #12
Health worker compliance with severe malaria treatment guidelines in the context of implementing pre-referral rectal artesunate in the Democratic Republic of the Congo, Nigeria, and Uganda: An operational study
202316 citationsauthor #26
Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso
20238 citationsauthor #8
Key factors predicting suspected severe malaria case management and health outcomes: an operational study in the Democratic Republic of the Congo
202211 citationsauthor #6
Pre-referral rectal artesunate: no cure for unhealthy systems.
202210 citationsauthor #5
Effectiveness of rectal artesunate as pre-referral treatment for severe malaria in children under 5 years of age: a multi-country observational study
202230 citationsauthor #26
Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso
20224 citationsauthor #10
Defining clinical trial quality from the perspective of resource-limited settings: A qualitative study based on interviews with investigators, sponsors, and monitors conducting clinical trials in sub-Saharan Africa
20227 citationsauthor #4
Determinants of Patients’ Adherence to Malaria Treatment in the Democratic Republic of the Congo
20226 citationsauthor #2
Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership
202228 citationsauthor #3
Strategies and interventions to strengthen pharmacovigilance systems in low- and middle-income countries: a scoping review.
20221 citationsauthor #4
Health system readiness and the implementation of rectal artesunate for severe malaria in sub-Saharan Africa: an analysis of real-world costs and constraints.
20226 citationsauthor #25
Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso
202222 citationsauthor #10
Examining African contributions to global health: Reflections on knowledge circulation and innovation
20224 citationsauthor #3
Care Seeking and Treatment of Febrile Children with and without Danger Signs of Severe Disease in Northern Uganda: Results from Three Household Surveys (2018–2020)
20228 citationsauthor #15
Acceptability of pre-referral rectal artesunate for severe malaria in children under 5 years by health workers and caregivers in the Democratic Republic of the Congo, Nigeria and Uganda
202210 citationsauthor #17
Health worker compliance with severe malaria treatment guidelines in the context of implementing pre-referral rectal artesunate: an operational study in three high burden countries
20219 citationsauthor #26
Recognition and management of clinically significant drug-drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionnaire-based study.
20214 citationsauthor #7
Community access to rectal artesunate for malaria (CARAMAL): A large-scale observational implementation study in the Democratic Republic of the Congo, Nigeria and Uganda
202129 citationsauthor #2
Methodological approaches for conducting follow-up research with clinical trial participants: a scoping review and expert interviews
202114 citationsauthor #5
Danger signs and management of suspected severe malaria cases at community level and in referral health facilities: an operational study in the Democratic Republic of the Congo
20213 citationsauthor #6
Effectiveness of rectal artesunate as pre-referral treatment for severe malaria in children <5 years of age
202113 citationsauthor #26
Transparent reporting of recruitment and informed consent approaches in clinical trials recruiting children with minor parents in sub-Saharan Africa: a secondary analysis based on a systematic review
20210 citationsauthor #3
Acceptability of Rectal Artesunate as pre-referral treatment for severe malaria in children under 5 years by health workers and caregivers in the Democratic Republic of the Congo, Nigeria and Uganda
20211 citationsauthor #17
Modelling the impact of fexinidazole use on human African trypanosomiasis transmission in the Democratic Republic of Congo
20210 citationsauthor #3
Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo
20214 citationsauthor #3
Clonal Expansion of Artemisinin-Resistant Plasmodium Falciparum in Uganda is Associated with Substandard Treatment Practices
20217 citationsauthor #16
Starting at the community: Treatment-seeking pathways of children with suspected severe malaria in Uganda
202112 citationsauthor #16
Prereferral rectal artesunate and referral completion among children with suspected severe malaria in the Democratic Republic of the Congo, Nigeria and Uganda
202122 citationsauthor #24
Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study
202112 citationsauthor #12
Knowledge of Antimalarials and Health Seeking Behaviour of Households in Case of Suspected Malaria in Democratic Republic of the Congo
202112 citationsauthor #2
Informed consent approaches for clinical trial participation of infants with minor parents in sub-Saharan Africa: A systematic review
20208 citationsauthor #3
Sleeping Sickness at the Crossroads
20207 citationsauthor #1
Gambiense Human African Trypanosomiasis Sequelae after Treatment: A Follow-Up Study 12 Years after Treatment
202011 citationsauthor #8
Sleeping hearts: 12 years after a follow up study on cardiac findings due to sleeping sickness
20206 citationsauthor #4
Clinical Study on the Melarsoprol-Related Encephalopathic Syndrome: Risk Factors and HLA Association
202012 citationsauthor #7
New Drugs for Human African Trypanosomiasis: A Twenty First Century Success Story
2020112 citationsauthor #5
Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo
201916 citationsauthor #10
The Flipside of Eradicating a Disease; Human African Trypanosomiasis in a Woman in Rural Democratic Republic of Congo: A Case Report
20195 citationsauthor #4
Drug use in the management of uncomplicated malaria in public health facilities in the Democratic Republic of the Congo
201826 citationsauthor #2
IMPROVING EFFICIENCY AND QUALITY IN CLINICAL TRIALS IN SUB-SAHARAN AFRICA
20172 citationsauthor #3
Abstracts of the Eighth EDCTP Forum, 6–9 November 2016
20170 citationsauthor #881
Contribution of adverse events reporting of HIV antiretrovirals to vigibase : comparison between Sub-Saharan Africa and the rest of the world
20170 citationsauthor #8
Spontaneous reporting characteristics of HIV antiretrovirals in vigibase: disproportionate analysis between Sub-Saharan Africa and the rest of the world
20170 citationsauthor #8
110 – Human African Trypanosomiasis
20170 citationsauthor #1
Increasing protocol suitability for clinical trials in sub-Saharan Africa: a mixed methods study
20178 citationsauthor #4
Feasibility and acceptability of injectable artesunate for the treatment of severe malaria in the Democratic Republic of Congo
20168 citationsauthor #3
Efficacy, Safety, and Dose of Pafuramidine, a New Oral Drug for Treatment of First Stage Sleeping Sickness, in a Phase 2a Clinical Study and Phase 2b Randomized Clinical Studies
201621 citationsauthor #1
Feasibility and acceptability of injectable artesunate for the treatment of severe malaria in the Democratic Republic of Congo
20160 citationsauthor #3
Efficacy and Safety of Pafuramidine versus Pentamidine Maleate for Treatment of First Stage Sleeping Sickness in a Randomized, Comparator-Controlled, International Phase 3 Clinical Trial
201634 citationsauthor #4
An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study
20150 citationsauthor #3
An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study
201522 citationsauthor #3
Delayed Anemia after Treatment with Injectable Artesunate in the Democratic Republic of the Congo: A Manageable Issue
201427 citationsauthor #1
45 – Human African Trypanosomiasis
2014290 citationsauthor #1
Antiprotozoals for human African trypanosomiasis : the heart of darkness at dawn
20141 citationsauthor #1
Consensus standards for introductory e-learning courses in human participants research ethics
20137 citationsauthor #7
Safety and Efficacy of the 10-Day Melarsoprol Schedule for the Treatment of Second Stage Rhodesiense Sleeping Sickness
201258 citationsauthor #9
An alternative form of melarsoprol in sleeping sickness: is an old drug always the best basis for a new one?
20125 citationsauthor #1
Prevention--a cost-effective way to fight the non-communicable disease epidemic: an academic perspective of the United Nations High-level NCD Meeting.
201142 citationsauthor #4
Clinical Presentation of T.b. rhodesiense Sleeping Sickness in Second Stage Patients from Tanzania and Uganda
201166 citationsauthor #5
Mycobacterium Tuberculosis Genetic Diversity and Drug Resistance Conferring Mutations in the Democratic Republic of the Congo
20110 citationsauthor #8
Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring
201143 citationsauthor #5
Diamidines for human African trypanosomiasis.
2010106 citationsauthor #9
Chemotherapy against human African trypanosomiasis: Is there a road to success?
2010113 citationsauthor #1
Comparative Detection of Trypanosomal DNA by Loop-Mediated Isothermal Amplification and PCR from Flinders Technology Associates Cards Spotted with Patient Blood
201051 citationsauthor #5
Human African trypanosomiasis
20101,206 citationsauthor #4
Cardiac Alterations in Human African Trypanosomiasis (T.b. gambiense) with Respect to the Disease Stage and Antiparasitic Treatment
200938 citationsauthor #3
Reflections on clinical research in sub-Saharan Africa.
200916 citationsauthor #2
Cardiac involvement in African and American trypanosomiasis.
200869 citationsauthor #3
Sleeping glands? - The role of endocrine disorders in sleeping sickness (T.b. gambiense Human African Trypanosomiasis).
200721 citationsauthor #8
Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis)
200749 citationsauthor #2
Clinical aspects of 2541 patients with second stage human African trypanosomiasis.
2006160 citationsauthor #3
Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).
2005107 citationsauthor #11
Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness.
200474 citationsauthor #5
Current chemotherapy of human African trypanosomiasis.
200427 citationsauthor #1
Christian Burri and Substitutions Fluoroquinolones with Pyrrolidinyl Antitrypanosomal Activities of
20030 citationsauthor #3
Eflornithine for the treatment of human African trypanosomiasis
2003200 citationsauthor #1
Antitrypanosomal Activities of Fluoroquinolones with Pyrrolidinyl Substitutions
200332 citationsauthor #3
An unusual type IB topoisomerase from African trypanosomes
200355 citationsauthor #4
Treatment of human African trypanosomiasis--present situation and needs for research and development.
2002263 citationsauthor #5
Evaluation of quinolone derivatives for antitrypanosomal activity
200122 citationsauthor #2
The story of CGP 40 215: studies on its efficacy and pharmacokinetics in African green monkey infected with Trypanosoma brucei rhodesiense
200112 citationsauthor #2
The phenomenon of treatment failures in Human
200110 citationsauthor #5
The phenomenon of treatment failures in Human African Trypanosomiasis
2001207 citationsauthor #5
Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment
200173 citationsauthor #1
New drugs for the treatment of human African trypanosomiasis: research and development.
200184 citationsauthor #2
Editorial: Are there new approaches to roll back trypanosomiasis?
20014 citationsauthor #1
Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis
2001138 citationsauthor #3
Physico-chemical properties of the trypanocidal drug melarsoprol.
200018 citationsauthor #2
An automated biological assay to determine levels of the trypanocidal drug melarsoprol in biological fluids.
200024 citationsauthor #2
Investigations of the metabolites of the trypanocidal drug melarsoprol
200055 citationsauthor #3
Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial.
2000169 citationsauthor #1
Antitrypanosomal Activity of Fluoroquinolones
199940 citationsauthor #2
Topoisomerases in kinetoplastids.
199637 citationsauthor #1
Alternative application of melarsoprol for treatment of T. B. gambiense sleeping sickness. Preliminary results.
199519 citationsauthor #1
Antiparasitic activity of diallyl trisulfide (Dasuansu) on human and animal pathogenic protozoa (Trypanosoma sp., Entamoeba histolytica and Giardia lamblia) in vitro.
199478 citationsauthor #2
Pharmacokinetic properties of the trypanocidal drug melarsoprol.
199382 citationsauthor #1
An in vitro bioassay for quantification of melarsoprol in serum and cerebrospinal fluid.
199219 citationsauthor #1

TIMELINE

1992 19 citations

1993 82 citations

1994 78 citations

1995 19 citations

1996 37 citations

1999 40 citations

2000 266 citations

2001 550 citations

2002 263 citations

2003 287 citations

2004 101 citations

2005 107 citations

2006 160 citations

2007 70 citations

2008 69 citations

2009 54 citations

2010 1,476 citations

2011 151 citations

2012 63 citations

2013 7 citations

2014 318 citations

2015 22 citations

2016 63 citations

2017 10 citations

2018 26 citations

2019 21 citations

2020 156 citations

2021 142 citations

2022 147 citations

2023 26 citations

C. Burri

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT